ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Clinical trial NCT05405595 · RECRUITING
Trial details
- NCT number
- NCT05405595
- Sponsor
- Adagene Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2026-10-31
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.